adstiladrin - nadofaragene firadenovec - vncg suspension
(Nadofaragene Firadenovec-Vncg)Ferring Pharmaceuticals Inc.
Usage: Adstiladrin treats adults with high-risk BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ, with or without papillary tumors.